Femamed 2.5
87.00$
| ACTIVE HALF-LIFE: | 2-4 days |
| CLASSIFICATION: | Non-steroidal aromatase inhibitor |
| DOSAGE: | 2.5-5 mg/day |
| ACNE: | No |
| WATER RETENTION: | No |
| HBR: | No |
| HEPATOTOXICITY: | No |
| AROMATIZATION: | No |
| MANUFACTURER: | Deus Medical – US |
| LAB TEST: | See Document |
| WAREHOUSE: | USA Warehouse 6 |
| SUBSTANCE: | Letrozole |
FEMAMED 2.5 (Letrozole) belongs to a group of medicines called aromatase inhibitors. It is a hormonal (or “endocrine”) breast cancer treatment. Growth of breast cancer is frequently stimulated by estrogens which are female sex hormones.
FEMAMED 2.5 reduces the amount of estrogen by blocking an enzyme (“aromatase”) involved in the production of estrogens and therefore may block the growth of breast cancer that needs estrogens to grow.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.